BRIACELL THERAPEUTICS CORP. Interest Expense
BRIACELL THERAPEUTICS CORP. (BCTX) reported Interest Expense of $979 for the 9-month period ending 2022-04-30, per its 6-K filed 2022-06-13.
Discontinued › Expense Statement › Interest Expense
ifrs-full:InterestExpense · last filed 2022-06-13
- BRIACELL THERAPEUTICS CORP. interest expense for the quarter ending 2022-04-30 was $0.00, a 100.00% decline year-over-year.
- BRIACELL THERAPEUTICS CORP. interest expense for the quarter ending 2021-07-31 was -$77.83K.
- BRIACELL THERAPEUTICS CORP. interest expense for the quarter ending 2021-04-30 was $62.42K.
- BRIACELL THERAPEUTICS CORP. interest expense for the quarter ending 2021-01-31 was $45.79K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2022-04-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2022-06-13 | $979.00 6-K · filed 2022-06-13 | ||
| 2022-01-31 | $979.00 6-K · filed 2022-03-15 | |||
| 2021-07-31 | -$77.83K derived: 40-F/A 12 month − 6-K 9 month · filed 2021-11-16 | -$15.41K derived: sum of 2 quarters · filed 2022-06-13 | $30.37K derived: sum of 3 quarters · filed 2022-06-13 | $46.09K 40-F/A · filed 2021-11-16 |
| 2021-04-30 | $62.42K 6-K · filed 2022-06-13 | $108.20K derived: sum of 2 quarters · filed 2022-06-13 | $123.93K 6-K · filed 2022-06-13 | |
| 2021-01-31 | $45.79K 6-K · filed 2022-03-15 | $61.51K 6-K · filed 2022-03-15 | ||
| 2020-07-31 | $29.48K 40-F/A · filed 2021-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |